Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-004878
Filing Date
2025-08-12
Accepted
2025-08-12 11:24:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12835
  Complete submission text file 0001085146-25-004878.txt   14817
Mailing Address ONE VANDERBILT AVENUE NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE NEW YORK NY 10017 212-827-6971
TD SECURITIES (USA) LLC (Filed by) CIK: 0000803012 (see all company filings)

EIN.: 581495511 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SCHEDULE 13G/A

Mailing Address 437 MADISON AVENUE 27TH FLOOR NEW YORK NY 10022
Business Address 437 MADISON AVENUE 27TH FLOOR NEW YORK NY 10022 6469785180
Denali Capital Acquisition Corp. (Subject) CIK: 0001913577 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93795 | Film No.: 251205177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)